- $5.75m
- $5.32m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | n/a | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | -2.67% | ||
Operating Margin | n/a |
Financial Summary
Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Nukkleus Inc. is a financial technology company focused on providing software and technology solutions for the worldwide crypto and retail foreign exchange (FX) trading industry. The Company primarily provides its software, technology, customer sales and marketing and risk management technology hardware and software solutions package to Triton Capital Markets Ltd. (TCM). The FXDD brand is the brand utilized in the retail forex trading industry by TCM. It provides software technology and technical support to TCM in each of these seven service categories: Introducing Broker Dealer Network and the Introducing Broker Interface; Chinese and Middle East customer desk support; Bridging software to the XWare (MT4 and MT5) platforms; Forex Market Liquidity Access; Turnkey risk management support software and Risk Management Team; Front End Software Retail Trading Platforms and Customer Application Systems, and Back Office Systems management.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- December 22nd, 2023
- Public Since
- February 8th, 2021
- No. of Shareholders
- 7
- Sector
- Investment Banking & Investment Services
- Industry
- Financials
- Exchange
NASDAQ Global Market
- Shares in Issue
- 14,820,788
![Blurred out image of a map](https://www.stockopedia.com/assets/conversion/images/maps_placeholder.jpg)
- Address
- 16192 Coastal Highway, Sussex County, JERSEY CITY, 07310
- Web
- https://www.nukk.com
- Phone
- Auditors
- Marcum Asia CPAs LLP
Upcoming Events for NUKK
Similar to NUKK
180 Degree Capital
NASDAQ Global Market
9F
NASDAQ Global Market
Binah Capital
NASDAQ Global Market
Bitfarms
NASDAQ Global Market
B Riley Financial
NASDAQ Global Market
FAQ
As of Today at 22:25 UTC, shares in Nukkleus are trading at $0.70. This share price information is delayed by 15 minutes.
Shares in Nukkleus last closed at $0.70 and the price had moved by -91.34% over the past 365 days. In terms of relative price strength the Nukkleus share price has underperformed the S&P500 Index by -93.11% over the past year.
There is no consensus recommendation for this security.
Nukkleus does not currently pay a dividend.
Nukkleus does not currently pay a dividend.
Nukkleus does not currently pay a dividend.
To buy shares in Nukkleus you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.70, shares in Nukkleus had a market capitalisation of $10.41m.
Here are the trading details for Nukkleus:
- Country of listing: United States
- Exchange: NMQ
- Ticker Symbol: NUKK
Based on an overall assessment of its quality, value and momentum Nukkleus is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Nukkleus. Over the past six months, its share price has underperformed the S&P500 Index by -81.73%.
As of the last closing price of $0.70, shares in Nukkleus were trading -80.93% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Nukkleus PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.70.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Nukkleus' directors